piroxantrone has been researched along with Stomach Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gluck, WL; Hantel, A; Macdonald, JS; Tangen, C | 1 |
| Brandof, JE; Bready, B; Close, DR; Kolbye, S; Pazdur, R; Scalzo, AJ; Winn, RJ | 1 |
2 trial(s) available for piroxantrone and Stomach Neoplasms
| Article | Year |
|---|---|
Phase II trial of piroxantrone in gastric carcinoma. A Southwest Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Anthraquinones; Antineoplastic Agents; Female; Humans; Male; Middle Aged; Pyrazoles; Stomach Neoplasms | 1994 |
Phase II trial of piroxantrone in metastatic gastric adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anemia; Anthraquinones; Antineoplastic Agents; Fatigue; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Pyrazoles; Stomach Neoplasms; Vomiting | 1994 |